The nation of Zimbabwe has declined a substantial US health deal worth $367m (£272m) spanning five years because of Washington's request for sensitive data.
This move became public following a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "skewed".
An official spokesperson later stated that the US was requesting genetic material for scientific study and profit but refused to share the benefits from future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more dialogue to find a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Context
Zimbabwe's decision follows a comparable situation in Kenya, where a court halted a similar health funding agreement following concerns were filed about the security of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our people should a new health crisis arise."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks previously established via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent co-operation could be structured in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body said it recognised the government's concerns, but recommended that negotiations must proceed considering a large portion of the nation's Aids initiatives were funded by foreign aid.
"In cases where technical issues exist, including those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.
The halted deal emphasises the complex challenges between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.